ROME, ITALY — Using the factor Xa inhibitor edoxaban (Savaysa/Lixiana, Daiichi Sankyo) to anticoagulate patients about to undergo electrical cardioversion for their atrial fibrillation (AF) seems ...

All the selected patients for the study were under antiarrhythmic drug treatment (amiodarone 200 mg/day) before the procedure and during the whole follow-up after ECV. Moreover, all of them were also ...